Tramadol oral solution: new drug. Poorly evaluated and potentially dangerous in children

    Insights

    Codeine is the standard step-2 opiate analgesic for children. Tramadol, a newer option, has limited trial data, potential harm, and unproven efficacy in pediatric pain management.

    Area of Science:

    • Pediatric Pharmacology
    • Pain Management
    • Drug Safety

    Background:

    • Codeine is the established step-2 opiate analgesic for children aged one year and older.
    • Tramadol, a step-2 opiate analgesic, is now approved for children aged three and older in France.

    Purpose of the Study:

    • To evaluate the evidence supporting the use of tramadol in pediatric pain management.
    • To compare the efficacy and safety of tramadol with existing analgesics in children.

    Main Methods:

    • Review of existing clinical trials and safety data for tramadol in pediatric populations.
    • Analysis of comparative studies between tramadol and other analgesics like codeine, paracetamol, and ibuprofen.

    Main Results:

    • Clinical trials for tramadol in children are limited to short-term postoperative pain.
    • Tramadol has not been directly compared to codeine or properly dosed paracetamol in pediatric trials.
    • Adverse effects of tramadol in children, such as vomiting, are frequent, and deaths from overdose have been reported, similar to codeine.

    Conclusions:

    • There is insufficient evidence to support the efficacy of tramadol in children.
    • The potential risks associated with tramadol in pediatric patients outweigh the documented benefits.
    • Prescribing tramadol for pediatric pain management is not currently justified due to its poorly documented efficacy and safety concerns.

    Related Concept Videos

    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    Prescription, Nonprescription and Orphan Drugs01:02

    Prescription, Nonprescription and Orphan Drugs

    Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
    The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

    Opioid Analgesics: Synthetic and Semisynthetic Opioids

    Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
    Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

    Sedatives and Hypnotics Drugs: Miscellaneous Agents

    Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
    Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...